• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Precision medicine in hematological malignancies].

作者信息

Yasuda Takahiko, Horibe Keizo

机构信息

Nagoya Medical Center, Clinical Research Center.

出版信息

Rinsho Ketsueki. 2019;60(9):1386-1395. doi: 10.11406/rinketsu.60.1386.

DOI:10.11406/rinketsu.60.1386
PMID:31597868
Abstract

Precision medicine is a type of medical care designed to optimize the therapeutic efficiency or benefit for particular groups of patients with the use of genetic profiling. The application of precision medicine in cancer treatment is prospected because cancer is reported to be the leading cause of death in Japan. Consequently, Japanese cancer genome medicine will be launched within this fiscal year. In this study, we focus on precision medicine specifically in the field of hematological malignancies with an overview of its clinical utility. We further discuss how precision medicine should be developed in this field, based on our experience of a feasibility study for clinical sequencing in hematological malignancies.

摘要

相似文献

1
[Precision medicine in hematological malignancies].
Rinsho Ketsueki. 2019;60(9):1386-1395. doi: 10.11406/rinketsu.60.1386.
2
Novel precision medicine approaches and treatment strategies in hematological malignancies.血液系统恶性肿瘤的新型精准医学方法和治疗策略。
J Intern Med. 2023 Oct;294(4):413-436. doi: 10.1111/joim.13697. Epub 2023 Aug 7.
3
[NGS-based multi-gene panel testing in hematological malignancies: diagnosis and prognostic prediction].基于二代测序的血液系统恶性肿瘤多基因panel检测:诊断与预后预测
Rinsho Ketsueki. 2022;63(4):294-301. doi: 10.11406/rinketsu.63.294.
4
[Transcriptome sequencing to promote research and clinical practice in precision medicine of hematologic malignancy].[转录组测序促进血液系统恶性肿瘤精准医学的研究与临床实践]
Zhonghua Yi Xue Za Zhi. 2021 Apr 6;101(13):899-903. doi: 10.3760/cma.j.cn112137-20201013-02824.
5
Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.精准医学和新型分子靶向治疗在急性髓系白血病中的应用:血液恶性肿瘤(HM)-SCREEN-Japan 01 的背景。
Int J Clin Oncol. 2019 Aug;24(8):893-898. doi: 10.1007/s10147-019-01467-1. Epub 2019 May 20.
6
[Genomics-based precision medicine in hematology/oncology].[血液学/肿瘤学中基于基因组学的精准医学]
Rinsho Ketsueki. 2021;62(8):1004-1011. doi: 10.11406/rinketsu.62.1004.
7
The current status and problems confronted in delivering precision medicine in Japan and Europe.日本和欧洲在提供精准医疗方面面临的现状与问题。
Curr Probl Cancer. 2017 May-Jun;41(3):166-175. doi: 10.1016/j.currproblcancer.2017.02.003. Epub 2017 Feb 22.
8
Regional social system for specialized medical care in hematologic malignancies: a pilot study.血液系统恶性肿瘤专科医疗的区域社会系统:一项试点研究。
Rural Remote Health. 2009 Jul-Sep;9(3):1106. Epub 2009 Jul 28.
9
[113th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Treatment of Hematological Malignancies in Rapidly Aging Society].[日本内科学会第113届科学会议:教育讲座:快速老龄化社会中血液系统恶性肿瘤的治疗]
Nihon Naika Gakkai Zasshi. 2016 Sep;105(9):1877-84.
10
An Empirical Study of the Prescription Pattern of Drugs for Hematological Malignancies in Japan from 2010-2014.2010 - 2014年日本血液系统恶性肿瘤药物处方模式的实证研究
Biol Pharm Bull. 2017;40(6):894-901. doi: 10.1248/bpb.b17-00111.